AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33337492 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous pinning
Number of subjects: 146
Study 33337492 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay in surgery (1 week)
Number of subjects: 146
Study 33337492 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pain (10-point increase)
Number of subjects: 146
Study 33576003 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-Enhanced Ultrasound (CEUS)
Number of subjects: 214
Study 33576003 — intervention group
Group type: COMPARATOR
Intervention: Standard Ultrasound
Number of subjects: 214
Study 33576003 — intervention group
Group type: COMPARATOR
Intervention: Computed Tomography (CT)
Number of subjects: 214
Study 33576003 — intervention group
Group type: COMPARATOR
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 214
Study 33567953 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) in addition to a 6-week exercise program
Number of subjects: 80
Study 33567953 — intervention group
Group type: COMPARATOR
Intervention: Control group received a 6-week exercise program alone
Number of subjects: 80
Study 33723919 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 0.5 mg/kg
Number of subjects: 0
Study 33723919 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 1 mg/kg
Number of subjects: 0
Study 33723919 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 2 mg/kg
Number of subjects: 0
Study 33723919 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD (all doses)
Number of subjects: 0
Study 32762279 — intervention group
Group type: EXPERIMENTAL
Intervention: Male Veterans
Number of subjects: 599
Study 32762279 — intervention group
Group type: COMPARATOR
Intervention: Male civilians
Number of subjects: 599
Study 35351371 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab alone (arm A)
Number of subjects: 112
Study 35351371 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab plus Paclitaxel (arm B)
Number of subjects: 112
Study 34312821 — intervention group
Group type: EXPERIMENTAL
Intervention: Stellate ganglion blockade (SGB) with variable combinations of bupivacaine, lidocaine, ropivacaine, and dexamethasone
Number of subjects: 13
Study 34312821 — intervention group
Group type: EXPERIMENTAL
Intervention: Stellate ganglion blockade (SGB)
Number of subjects: 13
Study 34939343 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed bolus
Number of subjects: 75
Study 34939343 — intervention group
Group type: COMPARATOR
Intervention: Conventional bolus
Number of subjects: 75
Study 32024435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole prophylaxis
Number of subjects: 0
Study 32024435 — intervention group
Group type: COMPARATOR
Intervention: Control group (stopping cotrimoxazole)
Number of subjects: 0
Study 35057434 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g/d salt (NaCl)
Number of subjects: 40
Study 35057434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32505790 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient endometrial sampling (OES)
Number of subjects: 266
Study 32505790 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic resectoscope-directed biopsies (HYbiopsy)
Number of subjects: 266
Study 32505790 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of OES and HYbiopsy
Number of subjects: 266
Study 32505790 — intervention group
Group type: COMPARATOR
Intervention: OES alone
Number of subjects: 266
Study 32505790 — intervention group
Group type: EXPERIMENTAL
Intervention: HYbiopsy
Number of subjects: 266
Study 36357586 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training with virtual reality (TT + VR)
Number of subjects: 124
Study 36357586 — intervention group
Group type: COMPARATOR
Intervention: Treadmill training alone (TT)
Number of subjects: 124
Study 33331835 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry supplementation (24 g d-1 for 90 days)
Number of subjects: 38
Study 32464260 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 28
Study 32464260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 32870478 — intervention group
Group type: EXPERIMENTAL
Intervention: CMAA and Montelukast
Number of subjects: 180
Study 32870478 — intervention group
Group type: EXPERIMENTAL
Intervention: CMAA
Number of subjects: 180
Study 32870478 — intervention group
Group type: COMPARATOR
Intervention: Montelukast
Number of subjects: 180
Study 36513296 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress + uncertain safety condition
Number of subjects: 147
Study 36513296 — intervention group
Group type: EXPERIMENTAL
Intervention: Less restrained individuals
Number of subjects: 147
Study 36513296 — intervention group
Group type: EXPERIMENTAL
Intervention: More restrained individuals
Number of subjects: 147
Study 36513296 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 147
Study 33451086 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (Sprint Interval Training)
Number of subjects: 32
Study 32236726 — intervention group
Group type: EXPERIMENTAL
Intervention: Molar incisor hypomineralization (MIH)
Number of subjects: 731
Study 32236726 — intervention group
Group type: EXPERIMENTAL
Intervention: GT/GG genotype in rs739837 polymorphism
Number of subjects: 731
Study 34397206 — intervention group
Group type: EXPERIMENTAL
Intervention: HP/TAZ (halobetasol propionate 0.01% and tazarotene 0.045%)
Number of subjects: 232
Study 34397206 — intervention group
Group type: EXPERIMENTAL
Intervention: HP/TAZ
Number of subjects: 232
Study 34397206 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 232
Study 32333875 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 3 mg
Number of subjects: 243
Study 32333875 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 7 mg
Number of subjects: 243
Study 32333875 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 14 mg
Number of subjects: 243
Study 32333875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study 32333875 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 0.9 mg
Number of subjects: 243
Study 35927708 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth HIIT exercise (16 weeks, 2 days per week)
Number of subjects: 0
Study 35927708 — intervention group
Group type: COMPARATOR
Intervention: No-exercise control group
Number of subjects: 0
Study 34582992 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrosurgical transection using a monopolar electrosurgical device (Bovie)
Number of subjects: 12
Study 34582992 — intervention group
Group type: COMPARATOR
Intervention: Sharp transection using a No. 10 scalpel blade
Number of subjects: 12
Study 33355949 — intervention group
Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 62
Study 33355949 — intervention group
Group type: COMPARATOR
Intervention: Voriconazole
Number of subjects: 62
Study 32750431 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-assisted intervention (couples participate in half of the group sessions and telephone calls)
Number of subjects: 0
Study 32750431 — intervention group
Group type: COMPARATOR
Intervention: Standard weight management program (individual participation)
Number of subjects: 0
Study 32750431 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-assisted intervention
Number of subjects: 0
Study 32750431 — intervention group
Group type: COMPARATOR
Intervention: Standard weight management program
Number of subjects: 0
Study 33802738 — intervention group
Group type: EXPERIMENTAL
Intervention: Paleolithic diet with supervised exercise
Number of subjects: 0
Study 33802738 — intervention group
Group type: COMPARATOR
Intervention: Paleolithic diet with general exercise recommendations
Number of subjects: 0
Study 35836116 — intervention group
Group type: EXPERIMENTAL
Intervention: ESP block with 0.375% ropivacaine (0.4 mL/kg)
Number of subjects: 3
Study 35836116 — intervention group
Group type: COMPARATOR
Intervention: SHAM block with 0.9% saline (0.4 mL/kg)
Number of subjects: 3
Study 35836116 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 3
Study 34269067 — intervention group
Group type: EXPERIMENTAL
Intervention: Tislelizumab plus concurrent chemoradiotherapy
Number of subjects: 0
Study 34269067 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus concurrent chemoradiotherapy
Number of subjects: 0
Study 32889533 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient tablet intervention in Gambian cohort
Number of subjects: 991
Study 32889533 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-based micronutrient intervention in Indian cohort
Number of subjects: 991
Study 35568330 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab (300 mg subcutaneous every 4 weeks)
Number of subjects: 0
Study 35568330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34260996 — intervention group
Group type: EXPERIMENTAL
Intervention: Papanicolaou cervical-cancer screening
Number of subjects: 0
Study 34260996 — intervention group
Group type: COMPARATOR
Intervention: Non-gender specific tests (blood-pressure and blood-sugar checks)
Number of subjects: 0
Study 33667113 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive wound closure (AWC) device for 3 months
Number of subjects: 14
Study 33667113 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 14
Study 33667113 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive wound closure (AWC) device
Number of subjects: 14
Study 32384291 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 20
Study 32384291 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg) + Magnesium sulfate (3g)
Number of subjects: 20
Study 32384291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32495573 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 42
Study 34148379 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT+CR (n=163)
Number of subjects: 332
Study 34148379 — intervention group
Group type: COMPARATOR
Intervention: Usual CR (n=169)
Number of subjects: 332
Study 36084236 — intervention group
Group type: EXPERIMENTAL
Intervention: Levagen+ (600 mg twice daily for 4 weeks)
Number of subjects: 60
Study 36084236 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice daily for 4 weeks)
Number of subjects: 60
Study 34042543 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 21
Study 34042543 — intervention group
Group type: COMPARATOR
Intervention: Conventional Therapy (Control)
Number of subjects: 21
Study 32492168 — intervention group
Group type: EXPERIMENTAL
Intervention: Pork intake
Number of subjects: 12
Study 32492168 — intervention group
Group type: EXPERIMENTAL
Intervention: Red meat intake
Number of subjects: 12
Study 32492168 — intervention group
Group type: COMPARATOR
Intervention: Habitual red and processed meat intake
Number of subjects: 12
Study 35273049 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose pyrazinamide (40 mg/kg) and rifampicin (35 mg/kg) along with standard doses of isoniazid and ethambutol
Number of subjects: 0
Study 35273049 — intervention group
Group type: COMPARATOR
Intervention: Standardised TB treatment (6-month regimen)
Number of subjects: 0
Study 35273049 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose pyrazinamide-rifampicin regimen
Number of subjects: 0
Study 33201227 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of moderate-intensity aerobic exercise
Number of subjects: 0
Study 32228143 — intervention group
Group type: EXPERIMENTAL
Intervention: Video consultations
Number of subjects: 0
Study 32228143 — intervention group
Group type: COMPARATOR
Intervention: In-hospital consultations
Number of subjects: 0
Study 34288106 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency treatment
Number of subjects: 69
Study 34288106 — intervention group
Group type: COMPARATOR
Intervention: Monopolar radiofrequency treatment
Number of subjects: 69
Study 33041145 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ibuprofen
Number of subjects: 139
Study 33041145 — intervention group
Group type: COMPARATOR
Intervention: Topical piroxicam
Number of subjects: 139
Study 36459051 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock-absorbing sole shoe
Number of subjects: 52
Study 36459051 — intervention group
Group type: COMPARATOR
Intervention: Traditional sole shoe
Number of subjects: 52
Study 33184083 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) 400 mg/100 mg two times per day for 5 days
Number of subjects: 300
Study 33184083 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (no treatment)
Number of subjects: 300
Study 33184083 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r)
Number of subjects: 300
Study 35340770 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component quality improvement intervention including: (1) quality improvement teams and administrative support, (2) improved transplant education for patients and healthcare providers, (3) access to support, (4) program-level performance monitoring.
Number of subjects: 27
Study 35340770 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 27
Study 34814488 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV positive cervical cancer patients
Number of subjects: 2110
Study 34814488 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV16 infection
Number of subjects: 2110
Study 34814488 — intervention group
Group type: EXPERIMENTAL
Intervention: Single infection
Number of subjects: 2110
Study 34814488 — intervention group
Group type: EXPERIMENTAL
Intervention: Double infection
Number of subjects: 2110
Study 34814488 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk HPV subtypes covered by nine-valence HPV vaccine
Number of subjects: 2110
Study 36166981 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 168
Study 36166981 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness (brief adolescent mindfulness; BAM)
Number of subjects: 168
Study 36166981 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent:provider alliance
Number of subjects: 168
Study 34429470 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic trajectory guidance device (iSYS1)
Number of subjects: 32
Study 34429470 — intervention group
Group type: COMPARATOR
Intervention: Manual frameless implantation (PAD)
Number of subjects: 32
Study 35953634 — intervention group
Group type: COMPARATOR
Intervention: 800 IU/day vitamin D3 supplementation (G1)
Number of subjects: 41
Study 35953634 — intervention group
Group type: EXPERIMENTAL
Intervention: 1800 IU/day vitamin D3 supplementation (G2)
Number of subjects: 41
Study 33809162 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaOCl) treatment for 30 minutes
Number of subjects: 74
Study 33809162 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 74
Study 33235072 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological nursing intervention
Number of subjects: 100
Study 33235072 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study 33740465 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-11050 (200 mg twice daily, taken with food; day 1-112)
Number of subjects: 200
Study 33740465 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (0.5 mg/day; day 1-112)
Number of subjects: 200
Study 33740465 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin (3 mg/day for seven doses, then 6 mg/day; day 1-112)
Number of subjects: 200
Study 33740465 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergocalciferol (5 mg on day 1, then 2.5 mg on day 28 and day 56)
Number of subjects: 200
Study 33740465 — intervention group
Group type: COMPARATOR
Intervention: Standard tuberculosis treatment (control group)
Number of subjects: 200
Study 32381808 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond Elect (PBE) in self-etch mode
Number of subjects: 100
Study 32381808 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond Active (PBA) in self-etch mode
Number of subjects: 100
Study 32381808 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-cured groups
Number of subjects: 100
Study 32381808 — intervention group
Group type: EXPERIMENTAL
Intervention: Apical third region
Number of subjects: 100
Study 32381808 — intervention group
Group type: COMPARATOR
Intervention: Prime & Bond XP (PBXP) as control
Number of subjects: 100
Study 35963790 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct referral of HPV positives to colposcopy
Number of subjects: 0
Study 35963790 — intervention group
Group type: EXPERIMENTAL
Intervention: Following HPV positives up with one repeat screen
Number of subjects: 0
Study 35963790 — intervention group
Group type: EXPERIMENTAL
Intervention: Following HPV positives up with two repeat screens
Number of subjects: 0
Study 35963790 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV algorithms with no follow-up for cytology negative HPV positive individuals
Number of subjects: 0
Study 35963790 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytology algorithm
Number of subjects: 0
Study 35963790 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-round screening
Number of subjects: 0
Study 34302325 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplementation of 200 mL milk fortified with 240 IU of ergocalciferol (vitamin D2)
Number of subjects: 235
Study 34302325 — intervention group
Group type: COMPARATOR
Intervention: 200 mL of plain milk (Control)
Number of subjects: 235
Study 35429416 — intervention group
Group type: EXPERIMENTAL
Intervention: 12,500 steps per day
Number of subjects: 79
Study 35429416 — intervention group
Group type: COMPARATOR
Intervention: 10,000 steps per day
Number of subjects: 79
Study 35429416 — intervention group
Group type: COMPARATOR
Intervention: 15,000 steps per day
Number of subjects: 79
Study 33544517 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet cupping (WC)
Number of subjects: 40
Study 33544517 — intervention group
Group type: COMPARATOR
Intervention: Dry cupping (DC)
Number of subjects: 40
Study 33326713 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg twice daily for 2 weeks)
Number of subjects: 748
Study 33326713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 748
Study 33326713 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 748
Study 33947501 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing games with toys made of medical materials
Number of subjects: 110
Study 33947501 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 110
Study 33030983 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g leucine (LEU) daily
Number of subjects: 34
Study 33030983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 35880872 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate
Number of subjects: 1100
Study 33930856 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilization (NM)
Number of subjects: 51
Study 33930856 — intervention group
Group type: COMPARATOR
Intervention: Sham neural mobilization (sham NM)
Number of subjects: 51
Study 36471444 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% lidocaine patch (LP5)
Number of subjects: 102
Study 36471444 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 102
Study 32381804 — intervention group
Group type: EXPERIMENTAL
Intervention: Locator attachment
Number of subjects: 20
Study 32381804 — intervention group
Group type: COMPARATOR
Intervention: Ball and socket (BS) attachment
Number of subjects: 20
Study 35713342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 35713342 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on treatment
Number of subjects: 25
Study 35713342 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy treatment
Number of subjects: 25
Study 34477037 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Empowerment Program (17 sessions, 60 minutes each, 3 sessions per week)
Number of subjects: 65
Study 34477037 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 65
Study 33252586 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard-soled shoe
Number of subjects: 96
Study 33252586 — intervention group
Group type: COMPARATOR
Intervention: Short leg cast
Number of subjects: 96
Study 32986758 — intervention group
Group type: EXPERIMENTAL
Intervention: TICW-RFA
Number of subjects: 77
Study 32986758 — intervention group
Group type: COMPARATOR
Intervention: SC-RFA
Number of subjects: 77
Study 35238805 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Injury and Osteoarthritis Outcome Score (KOOS)
Number of subjects: 618
Study 35238805 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified four-factor structure of KOOS (suggested but not validated)
Number of subjects: 618
Study 32199861 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 52
Study 32199861 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 52
Study 33154491 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal HD-tDCS
Number of subjects: 0
Study 33154491 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 0
Study 35999617 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg for 3 days; 10 mg/kg for 7 days)
Number of subjects: 796
Study 35999617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 796
Study 34888601 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer protective film (A1)
Number of subjects: 122
Study 34888601 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (A2)
Number of subjects: 122
Study 34888601 — intervention group
Group type: COMPARATOR
Intervention: Control group (A3)
Number of subjects: 122
Study 34888601 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer protective film (B1)
Number of subjects: 122
Study 34888601 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (B2)
Number of subjects: 122
Study 34888601 — intervention group
Group type: COMPARATOR
Intervention: Control group (B3)
Number of subjects: 122
Study 35028011 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 188